During a 17-week off-treatment follow-up period, people who had stopped using tirzepatide began to regain weight, Lilly said in a news release, and there was “some increase in the progression to ...

PARIS – Swimmers often say last one, fast one. For Lilly King, it was that, and more, in her last Olympic swim Sunday night at Nanterre, France. With King on breaststroke, the United States won ...

Eli Lilly’s drug tirzepatide, sold under the names Mounjaro for diabetes and Zepbound for weight loss, improved symptoms in heart failure patients with obesity, the company said Thursday.

NANTERRE, France — If Lilly King isn’t swimming, she just might be talking. As the gregarious voice of reason in American swimming, no issue is too controversial, no comment too incendiary.

NANTERRE, France – Lilly King was on top of the world, and on top of the podium, at the Rio Olympics eight years ago. It is harder to stay there than get there. Yet one-hundredth of a second ...

Eli Lilly & Co.’s blockbuster Zepbound improved the long-term health of patients with obesity-related heart failure in a study, illuminating the cardiovascular benefits of the weight-loss shot.

Eli Lilly and Company (NYSE: LLY) will attend the Morgan Stanley 22nd Annual Global Healthcare Conference on Sept. 5, 2024. Jacob Van Naarden, executive vice president and president, Lilly ...

The ad tie-up also includes custom 15-second ads starring Lily Collins, pause ads, and Google Lens tech that lets users shop ...

Aug 1 (Reuters) - Trial results show Eli Lilly's (LLY.N), opens new tab weight loss drug Zepbound reduces the risk of hospitalization, death and other outcomes for obese adults with a common type ...

Eli Lilly stock (NYSE: LLY) has seen its stock rise by around 50% this year, outperforming the broader indices, with the S&P 500 up over 15%. The stock now trades at 63x projected 2024 earnings of ...

WIRED is where tomorrow is realized. It is the essential source of information and ideas that make sense of a world in constant transformation. The WIRED conversation illuminates how technology is ...

On Tuesday, Eli Lilly unveiled a towering 346,000-square-foot laboratory in Boston’s Seaport District, a building that will house 500 of the company’s scientists — 300 of whom are still to ...